Skip to main content
Fig. 2 | Allergy, Asthma & Clinical Immunology

Fig. 2

From: The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2,4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathway

Fig. 2

Effects of AS1517499 on the severity of skin and histopathological characteristics of 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD) in BALB/c mice. Representative images acquired after treatment (upper panel), and AD-like histopathological changes revealed by H&E staining under a light microscope (20 × magnification) in mouse skin samples (below panel). The images are representatives of the following four groups (n = 10 per group): A\E vehicle control (VC), B\F AD, C\G corn oil treatment (COTR), and D\H AS1517499 treatment (AS) groups

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us